1 | 2024 comments off on | | | | | | 18 | 3.03% |
2 | 9 2024 comments off | | | | | | 9 | 1.52% |
3 | august 9 2024 comments | | | | | | 9 | 1.52% |
4 | august 8 2024 comments | | | | | | 7 | 1.18% |
5 | 8 2024 comments off | | | | | | 6 | 1.01% |
6 | – san diego ca | | | | | | | 5 | 0.84% |
7 | – los angeles ca | | | | | | | 4 | 0.67% |
8 | los angeles ca 90095 | | | | | | | 4 | 0.67% |
9 | rejection novo vs lilly | | | | | | | 3 | 0.51% |
10 | bets 700m on an | | | | | | | 3 | 0.51% |
11 | earnings recursion exscientia to | | | | | | | 3 | 0.51% |
12 | to merge qa with | | | | | | | 3 | 0.51% |
13 | merck pays 700m for | | | | | | | 3 | 0.51% |
14 | merge qa with genentech | | | | | | | 3 | 0.51% |
15 | ‘amgen india’ to be | | | | | | | 3 | 0.51% |
16 | mdma rejection novo vs | | | | | | | 3 | 0.51% |
17 | on mdma rejection novo | | | | | | | 3 | 0.51% |
18 | qa with genentech ceo | | | | | | | 3 | 0.51% |
19 | advertise with biotech networks | | | | | | | 3 | 0.51% |
20 | with genentech ceo and | | | | | | | 3 | 0.51% |
21 | 10 2024 comments off | | | | | | 3 | 0.51% |
22 | latest on mdma rejection | | | | | | | 3 | 0.51% |
23 | exscientia to merge qa | | | | | | | 3 | 0.51% |
24 | recursion exscientia to merge | | | | | | | 3 | 0.51% |
25 | merck bets 700m on | | | | | | | 3 | 0.51% |
26 | potential in immune diseases | | | | | | | 3 | 0.51% |
27 | comments off on merck | | | | | | 3 | 0.51% |
28 | – pasadena ca 91125 | | | | | | | 3 | 0.51% |
29 | in la’s urban environments? | | | | | | | 2 | 0.34% |
30 | los angeles anticipates landmark | | | | | | | 2 | 0.34% |
31 | find out science friday | | | | | | | 2 | 0.34% |
32 | to find out science | | | | | | | 2 | 0.34% |
33 | associate – thousand oaks | | | | | | | 2 | 0.34% |
34 | inaturalist to find out | | | | | | | 2 | 0.34% |
35 | research associate i – | | | | | | | 2 | 0.34% |
36 | staff research associate i | | | | | | | 2 | 0.34% |
37 | ketamine clinics los angeles | | | | | | | 2 | 0.34% |
38 | clinics los angeles anticipates | | | | | | | 2 | 0.34% |
39 | angeles anticipates landmark fda | | | | | | | 2 | 0.34% |
40 | lightfully behavioral health launches | | | | | | | 2 | 0.34% |